Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Chronic Obstructive Lung Disease | Research

Abnormal heart rate responses to exercise in non-severe COPD: relationship with pulmonary vascular volume and ventilatory efficiency

Authors: Minghui Shi, Shiwei Qumu, Siyuan Wang, Yaodie Peng, Lulu Yang, Ke Huang, Ruoxi He, Feng Dong, Hongtao Niu, Ting Yang, Chen Wang

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

Despite being a prognostic predictor, cardiac autonomic dysfunction (AD) has not been well investigated in chronic obstructive pulmonary disease (COPD). We aimed to characterise computed tomography (CT), spirometry, and cardiopulmonary exercise test (CPET) features of COPD patients with cardiac AD and the association of AD with CT-derived vascular and CPET-derived ventilatory efficiency metrics.

Methods

This observational cohort study included stable, non-severe COPD patients. They underwent clinical evaluation, spirometry, CPET, and CT. Cardiac AD was determined based on abnormal heart rate responses to exercise, including chronotropic incompetence (CI) or delayed heart rate recovery (HRR) during CPET.

Results

We included 49 patients with FEV1 of 1.2–5.0 L (51.1–129.7%), 24 (49%) had CI, and 15 (31%) had delayed HRR. According to multivariate analyses, CI was independently related to reduced vascular volume (VV; VV ≤ median; OR [95% CI], 7.26 [1.56–33.91]) and low ventilatory efficiency (nadir VE/VCO2 ≥ median; OR [95% CI], 10.67 [2.23–51.05]). Similar results were observed for delayed HRR (VV ≤ median; OR [95% CI], 11.46 [2.03–64.89], nadir VE/VCO2 ≥ median; OR [95% CI], 6.36 [1.18–34.42]).

Conclusions

Cardiac AD is associated with impaired pulmonary vascular volume and ventilatory efficiency. This suggests that lung blood perfusion abnormalities may occur in these patients. Further confirmation is required in a large population-based cohort.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 Report Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 Report
2.
go back to reference Vivekananthan DP, et al. Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol. 2003;42(5):831–8.CrossRefPubMed Vivekananthan DP, et al. Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol. 2003;42(5):831–8.CrossRefPubMed
3.
go back to reference Elhendy A, et al. Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia. J Am Coll Cardiol. 2003;42(5):823–30.CrossRefPubMed Elhendy A, et al. Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia. J Am Coll Cardiol. 2003;42(5):823–30.CrossRefPubMed
4.
go back to reference Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51(18):1725–33.CrossRefPubMed Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51(18):1725–33.CrossRefPubMed
5.
go back to reference Chaudhry S, et al. Abnormal heart-rate response during cardiopulmonary exercise testing identifies cardiac dysfunction in symptomatic patients with non-obstructive coronary artery disease. Int J Cardiol. 2017;228:114–21.CrossRefPubMed Chaudhry S, et al. Abnormal heart-rate response during cardiopulmonary exercise testing identifies cardiac dysfunction in symptomatic patients with non-obstructive coronary artery disease. Int J Cardiol. 2017;228:114–21.CrossRefPubMed
6.
go back to reference Laforgia P, et al. Exercise chronotropic incompetence phenotypes the level of cardiovascular risk and exercise gas exchange impairment in the general population. An analysis of the Euro-EX prevention trial. Eur J Prev Cardiol. 2020;27(5):526–35.CrossRefPubMed Laforgia P, et al. Exercise chronotropic incompetence phenotypes the level of cardiovascular risk and exercise gas exchange impairment in the general population. An analysis of the Euro-EX prevention trial. Eur J Prev Cardiol. 2020;27(5):526–35.CrossRefPubMed
7.
go back to reference Lauer MS, et al. Association of cigarette smoking with chronotropic incompetence and prognosis in the Framingham Heart Study. Circulation. 1997;96(3):897–903.CrossRefPubMed Lauer MS, et al. Association of cigarette smoking with chronotropic incompetence and prognosis in the Framingham Heart Study. Circulation. 1997;96(3):897–903.CrossRefPubMed
8.
go back to reference Wang H, et al. Attenuated heart rate recovery in children and adolescents with obstructive sleep apnea syndrome. Pediatr Res. 2021;89(4):900–4.CrossRefPubMed Wang H, et al. Attenuated heart rate recovery in children and adolescents with obstructive sleep apnea syndrome. Pediatr Res. 2021;89(4):900–4.CrossRefPubMed
9.
go back to reference Ramos RP, et al. Heart rate recovery in pulmonary arterial hypertension: relationship with exercise capacity and prognosis. Am Heart J. 2012;163(4):580–8.CrossRefPubMed Ramos RP, et al. Heart rate recovery in pulmonary arterial hypertension: relationship with exercise capacity and prognosis. Am Heart J. 2012;163(4):580–8.CrossRefPubMed
10.
go back to reference Spiesshoefer J, et al. Sympathetic and vagal nerve activity in COPD: pathophysiology, presumed determinants and underappreciated therapeutic potential. Front Physiol. 2022;13:919422.CrossRefPubMedPubMedCentral Spiesshoefer J, et al. Sympathetic and vagal nerve activity in COPD: pathophysiology, presumed determinants and underappreciated therapeutic potential. Front Physiol. 2022;13:919422.CrossRefPubMedPubMedCentral
11.
go back to reference Mohammed J, et al. Evidence for autonomic function and its influencing factors in subjects with COPD: a systematic review. Respir Care. 2015;60(12):1841–51.CrossRefPubMed Mohammed J, et al. Evidence for autonomic function and its influencing factors in subjects with COPD: a systematic review. Respir Care. 2015;60(12):1841–51.CrossRefPubMed
12.
go back to reference Andreas S, et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005;128(5):3618–24.CrossRefPubMed Andreas S, et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005;128(5):3618–24.CrossRefPubMed
13.
go back to reference Washko GR, et al. Arterial vascular pruning, right ventricular size, and clinical outcomes in Chronic Obstructive Pulmonary Disease. A longitudinal observational study. Am J Respir Crit Care Med. 2019;200(4):454–61.CrossRefPubMedPubMedCentral Washko GR, et al. Arterial vascular pruning, right ventricular size, and clinical outcomes in Chronic Obstructive Pulmonary Disease. A longitudinal observational study. Am J Respir Crit Care Med. 2019;200(4):454–61.CrossRefPubMedPubMedCentral
15.
go back to reference Mayr AK, et al. Impaired spontaneous Baroreceptor Reflex sensitivity in patients with COPD compared to healthy controls: the role of lung hyperinflation. Front Med (Lausanne). 2021;8:791410.CrossRefPubMed Mayr AK, et al. Impaired spontaneous Baroreceptor Reflex sensitivity in patients with COPD compared to healthy controls: the role of lung hyperinflation. Front Med (Lausanne). 2021;8:791410.CrossRefPubMed
16.
go back to reference Cherneva RV, Youroukova VM, Cherneva ZV. Dynamic hyperinflation, chronotropic intolerance and abnormal heart rate recovery in non-severe chronic obstructive pulmonary disease patients-reflections in the mirror. Pulmonology. 2022;28(6):440–8.CrossRefPubMed Cherneva RV, Youroukova VM, Cherneva ZV. Dynamic hyperinflation, chronotropic intolerance and abnormal heart rate recovery in non-severe chronic obstructive pulmonary disease patients-reflections in the mirror. Pulmonology. 2022;28(6):440–8.CrossRefPubMed
17.
go back to reference Koo MC et al. Quantitative computed tomography and visual emphysema scores: association with lung function decline. ERJ Open Res, 2023. 9(2). Koo MC et al. Quantitative computed tomography and visual emphysema scores: association with lung function decline. ERJ Open Res, 2023. 9(2).
18.
go back to reference Rahaghi FN et al. Pulmonary vascular density: comparison of findings on computed tomography imaging with histology. Eur Respir J, 2019. 54(2). Rahaghi FN et al. Pulmonary vascular density: comparison of findings on computed tomography imaging with histology. Eur Respir J, 2019. 54(2).
19.
go back to reference Phillips DB, et al. Impaired ventilatory efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: results from the CanCOLD Study. Am J Respir Crit Care Med. 2022;205(12):1391–402.CrossRefPubMed Phillips DB, et al. Impaired ventilatory efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: results from the CanCOLD Study. Am J Respir Crit Care Med. 2022;205(12):1391–402.CrossRefPubMed
20.
go back to reference Elbehairy AF, et al. Pulmonary Gas Exchange abnormalities in mild chronic obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance. Am J Respir Crit Care Med. 2015;191(12):1384–94.CrossRefPubMed Elbehairy AF, et al. Pulmonary Gas Exchange abnormalities in mild chronic obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance. Am J Respir Crit Care Med. 2015;191(12):1384–94.CrossRefPubMed
21.
go back to reference American Thoracic S. American College of Chest, ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.CrossRef American Thoracic S. American College of Chest, ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.CrossRef
22.
go back to reference Graham BL, et al. Standardization of Spirometry 2019 Update. An official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70–88.CrossRefPubMedPubMedCentral Graham BL, et al. Standardization of Spirometry 2019 Update. An official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70–88.CrossRefPubMedPubMedCentral
23.
go back to reference Balady GJ, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191–225.CrossRefPubMed Balady GJ, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191–225.CrossRefPubMed
24.
go back to reference Teopompi E, et al. Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity. Respir Care. 2014;59(7):1034–41.CrossRefPubMed Teopompi E, et al. Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity. Respir Care. 2014;59(7):1034–41.CrossRefPubMed
25.
26.
go back to reference Zweerink A, et al. Chronotropic incompetence in Chronic Heart failure. Circ Heart Fail. 2018;11(8):e004969.CrossRefPubMed Zweerink A, et al. Chronotropic incompetence in Chronic Heart failure. Circ Heart Fail. 2018;11(8):e004969.CrossRefPubMed
27.
go back to reference Duus LS et al. COPD: pulmonary vascular volume associated with cardiac structure and function. Int J Cardiovasc Imaging, 2023. Duus LS et al. COPD: pulmonary vascular volume associated with cardiac structure and function. Int J Cardiovasc Imaging, 2023.
28.
go back to reference Hueper K, et al. Pulmonary Microvascular Blood Flow in mild chronic obstructive Pulmonary Disease and Emphysema. The MESA COPD Study. Am J Respir Crit Care Med. 2015;192(5):570–80.CrossRefPubMedPubMedCentral Hueper K, et al. Pulmonary Microvascular Blood Flow in mild chronic obstructive Pulmonary Disease and Emphysema. The MESA COPD Study. Am J Respir Crit Care Med. 2015;192(5):570–80.CrossRefPubMedPubMedCentral
29.
go back to reference Santos S, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002;19(4):632–8.CrossRefPubMed Santos S, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002;19(4):632–8.CrossRefPubMed
30.
go back to reference Pistenmaa CL, et al. Pulmonary arterial pruning and longitudinal change in percent emphysema and lung function: the genetic epidemiology of COPD Study. Chest. 2021;160(2):470–80.CrossRefPubMedPubMedCentral Pistenmaa CL, et al. Pulmonary arterial pruning and longitudinal change in percent emphysema and lung function: the genetic epidemiology of COPD Study. Chest. 2021;160(2):470–80.CrossRefPubMedPubMedCentral
31.
go back to reference Estépar RS, et al. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013;188(2):231–9.CrossRefPubMedPubMedCentral Estépar RS, et al. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013;188(2):231–9.CrossRefPubMedPubMedCentral
32.
go back to reference Elbehairy AF, et al. Pulmonary vascular volume by Quantitative CT in dyspneic smokers with minor Emphysema. Copd. 2023;20(1):135–43.CrossRefPubMed Elbehairy AF, et al. Pulmonary vascular volume by Quantitative CT in dyspneic smokers with minor Emphysema. Copd. 2023;20(1):135–43.CrossRefPubMed
33.
go back to reference Kovacs G, et al. Pulmonary vascular involvement in Chronic Obstructive Pulmonary Disease. Is there a pulmonary vascular phenotype? Am J Respir Crit Care Med. 2018;198(8):1000–11.CrossRefPubMed Kovacs G, et al. Pulmonary vascular involvement in Chronic Obstructive Pulmonary Disease. Is there a pulmonary vascular phenotype? Am J Respir Crit Care Med. 2018;198(8):1000–11.CrossRefPubMed
34.
35.
go back to reference Kessler R, et al. Natural history of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164(2):219–24.CrossRefPubMed Kessler R, et al. Natural history of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164(2):219–24.CrossRefPubMed
36.
go back to reference Delgado-Ortiz L, et al. Physical activity and cardiac autonomic dysfunction in patients with chronic obstructive pulmonary disease: a cross-sectional analysis. Ann Phys Rehabil Med. 2022;65(3):101501.CrossRefPubMed Delgado-Ortiz L, et al. Physical activity and cardiac autonomic dysfunction in patients with chronic obstructive pulmonary disease: a cross-sectional analysis. Ann Phys Rehabil Med. 2022;65(3):101501.CrossRefPubMed
37.
go back to reference Leite MR, et al. Correlation between heart rate variability indexes and aerobic physiological variables in patients with COPD. Respirology. 2015;20(2):273–8.CrossRefPubMed Leite MR, et al. Correlation between heart rate variability indexes and aerobic physiological variables in patients with COPD. Respirology. 2015;20(2):273–8.CrossRefPubMed
38.
go back to reference Mazzuco A, et al. Are heart rate dynamics in the transition from rest to submaximal exercise related to maximal cardiorespiratory responses in COPD? Braz J Phys Ther. 2017;21(4):251–8.CrossRefPubMedPubMedCentral Mazzuco A, et al. Are heart rate dynamics in the transition from rest to submaximal exercise related to maximal cardiorespiratory responses in COPD? Braz J Phys Ther. 2017;21(4):251–8.CrossRefPubMedPubMedCentral
39.
go back to reference Besnier F, et al. Exercise training-induced modification in autonomic nervous system: an update for cardiac patients. Ann Phys Rehabil Med. 2017;60(1):27–35.CrossRefPubMed Besnier F, et al. Exercise training-induced modification in autonomic nervous system: an update for cardiac patients. Ann Phys Rehabil Med. 2017;60(1):27–35.CrossRefPubMed
40.
go back to reference Chick TW, et al. Recovery of gas exchange variables and heart rate after maximal exercise in COPD. Chest. 1990;97(2):276–9.CrossRefPubMed Chick TW, et al. Recovery of gas exchange variables and heart rate after maximal exercise in COPD. Chest. 1990;97(2):276–9.CrossRefPubMed
41.
go back to reference Hulo S, et al. Chronotropic incompetence can limit exercise tolerance in COPD patients with lung hyperinflation. Int J Chron Obstruct Pulmon Dis. 2016;11:2553–61.CrossRefPubMedPubMedCentral Hulo S, et al. Chronotropic incompetence can limit exercise tolerance in COPD patients with lung hyperinflation. Int J Chron Obstruct Pulmon Dis. 2016;11:2553–61.CrossRefPubMedPubMedCentral
Metadata
Title
Abnormal heart rate responses to exercise in non-severe COPD: relationship with pulmonary vascular volume and ventilatory efficiency
Authors
Minghui Shi
Shiwei Qumu
Siyuan Wang
Yaodie Peng
Lulu Yang
Ke Huang
Ruoxi He
Feng Dong
Hongtao Niu
Ting Yang
Chen Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-03003-y

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine